Stanford University Medical School established a positive partnership with a pharmaceutical company to offer an industry-sponsored resident elective course in a way that minimizes conflict of interest and has been accepted by the ACGME.
Physicians need to be aware of and guard against the liability risks of having nonphysician clinicians provide services that do not meet the standard of care of the practice due to the staff member's inadequate experience or supervision.
A physician argues that pharmaceutical industry support for residency programs creates a conflict of interest and compromises the educational integrity of the programs.
The morbidity and mortality conference serves an important educational role for physicians and underscores the importance of error disclosure in improving patient safety.
Dr Brady J. Heward joins Ethics Talk to discuss his article, coauthored with Drs Amy M. Yule and Peter R. Jackson: “How Should Harm Reduction Strategies Differ for Adolescents and Adults?”